Access Patients Safety Workshop 
MMJ Recs
MARCH 2, 2024
In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. This guide aims to demystify the process, offering practical advice and insights to help patients make informed decisions.
MMJ Recs
OCTOBER 2, 2023
California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Patients must first schedule an appointment with a licensed medical professional who can evaluate their medical history and condition. In 1996, the state became the first in the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MMJ Recs
MARCH 16, 2024
Regulations vary significantly by jurisdiction but typically encompass licensing requirements, product safety standards, and distribution protocols. Changes in regulations can have ripple effects throughout the industry, impacting supply chains, investment strategies, and consumer access to medical cannabis products.
Cannabis Law Report
SEPTEMBER 11, 2021
Under the supervision of the Executive Director of the Georgia Access to Medical Cannabis Commission. The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission.
Cannabis Law Report
JUNE 15, 2021
Under the supervision of the Executive Director of the Georgia Access to Medical Cannabis Commission. The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission.
Cannabis Law Report
SEPTEMBER 18, 2021
Under the supervision of the Executive Director of the Georgia Access to Medical Cannabis Commission. The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission.
Cannabis Law Report
MAY 18, 2022
A recent publication in the prominent peer-reviewed journal Nature, shows that 67% of patients no longer qualified for a PTSD diagnosis a year after treatment with MDMA (or “ecstasy”). READ DOC OF WHAT’S HAPPENING. The clinical evidence for psychedelic assisted therapy is accumulating.
Expert insights. Personalized for you.
52 
Let's personalize your content